Media Relations News Releases Year: - Any -202120202019201820172016 Items per page 102550 Sep 24, 2016 Summary ToggleNovartis receives three new FDA approvals for the expanded use of Ilaris® treating rare Periodic Fever Syndrome conditions Sep 23, 2016 Summary ToggleAlcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experience Sep 22, 2016 Summary ToggleNew Novartis data shows Cosentyx™ is significantly superior to Stelara® and clears skin (PASI 90) in nearly 80% of psoriasis patients Sep 21, 2016 Summary ToggleNovartis’ Cosentyx™ two-year data shows sustained effect and favorable safety profile in psoriasis patients Sep 15, 2016 Summary ToggleNovartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy Congress Sep 15, 2016 Summary ToggleNovartis presents new positive data at EHMTIC showing AMG 334 significantly reduces monthly migraine days in chronic migraine Sep 9, 2016 Summary ToggleNew Novartis point of care Niji™ System may provide earlier diagnosis of severe allergic asthma and faster treatment decisions Jun 29, 2016 Summary ToggleLargest global psoriasis survey shows 84% of people face discrimination and humiliation because of their skin Jun 10, 2016 Summary ToggleNovartis drug Afinitor® receives EU approval to treat certain types of advanced gastrointestinal (GI) and lung neuroendocrine tumors (NET) Jun 8, 2016 Summary ToggleNovartis presents new scientific evidence for Cosentyx in ankylosing spondylitis and psoriatic arthritis patients at EULAR 2016 Pagination First page First Previous page Previous … Page 9 Page 10 Current page 11 Page 12 Next page Next Last page Last